Lauren Rackers
Nurse Practitioner · Columbia, MONPI 1134890866
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,499 of the $5,463 with a category attached, or 82.4%. It is spread thinly across 42 manufacturers, the largest accounting for just 9.9% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $22.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$541
- Merck$458
- E.r. Squibb & Sons, L.L.C.$320
- Pfizer$314
- Sobi, Inc$290
- Novartis$285
- plus $3K from 36 others
What the payments were for
- Food & beverage$4,49982%
- Education$96418%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $541 |
| Merck | 21 | $458 |
| E.r. Squibb & Sons, L.L.C. | 23 | $320 |
| Pfizer | 12 | $314 |
| Sobi, Inc | 7 | $290 |
| Novartis | 15 | $285 |
| Gilead | 5 | $283 |
| AstraZeneca(2 entities) | 15 | $273 |
| Incyte Corporation | 10 | $241 |
| AbbVie | 6 | $216 |
| Lilly USA, LLC | 5 | $185 |
| Genentech USA, Inc. | 11 | $168 |
| Regeneron Healthcare Solutions, Inc. | 6 | $136 |
| Dendreon Pharmaceuticals LLC | 6 | $129 |
| EMD Serono, Inc. | 7 | $127 |
| Sanofi | 6 | $110 |
| Astellas Pharma US Inc | 2 | $108 |
| Daiichi Sankyo Inc. | 4 | $104 |
| Stemline Therapeutics Inc. | 5 | $97 |
| GSK | 4 | $94 |
| Eisai Inc. | 4 | $87 |
| Genmab U.S., Inc. | 4 | $87 |
| Sanofi-aventis U.S. LLC | 1 | $78 |
| Exelixis Inc. | 3 | $77 |
| Bayer | 3 | $77 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $75 |
| Taiho Oncology, Inc. | 4 | $65 |
| Bristol Myers Squibb | 3 | $59 |
| Puma Biotechnology, Inc. | 3 | $56 |
| Legend Biotech USA Inc. | 2 | $51 |
| Boehringer Ingelheim | 2 | $46 |
| Jazz Pharmaceuticals Inc. | 2 | $39 |
| Edwards Lifesciences | 1 | $29 |
| Geron Corporation | 1 | $24 |
| Karyopharm Therapeutics Inc. | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Pharmaand GmbH | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
| Mirati Therapeutics, Inc. | 1 | $17 |
| Atricure, Inc. | 1 | $17 |
| Blue Earth Diagnostics | 1 | $15 |
| Servier Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Trodelvy$132
How this compares
$5,463 in reported general payments places this provider in the 90th percentile of 1,898 nurse practitioner providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron OdtOndansetron | 17 | $313 |
| Levofloxacin | 22 | $116 |
| Potassium Chloride | 13 | $65 |
| Furosemide | 12 | $18 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Columbia
- Janet SamuelsColumbia$19K
- Kwai Mung ChinColumbia$17K
- Jonathan BarnesColumbia$10K
- Aeron SheffieldChesterfield$269K
- Rachel ImperatoOsage Beach$260K
- Matthew BrunsBridgeton$126K
- Michelle DickensSpringfield$59K
- Robert HafnerKansas City$47K
- Tracey CarpenterChesterfield$47K
- Laura GrantSaint Charles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.